Non-structural protein 9 of SARS-CoV-2 (Nsp9)

Non-structural protein 9 (Nsp9) of SARS-CoV-2 is a small, 113-amino-acid RNA-binding protein encoded by ORF1a, essential for viral replication and pathogenesis[1][2][3][4]. It forms homodimers via a conserved GxxxG motif and typically prefers to bind single-stranded RNA (ssRNA)[1][3][4]. The core structure is a β-barrel composed of seven β-strands and one C-terminal α-helix; this fold is unique to coronaviruses[1][2][3]. Nsp9 participates in the viral replication complex, stabilizing nascent viral RNA, and possibly facilitating its synthesis and protection from nucleases[1][7]. In addition to its structural role, SARS-CoV-2 Nsp9 interacts with host proteins such as nucleoporin 62 (NUP62), impairing nuclear transport and thereby contributing to immune evasion[5]. It also interferes with the host signal recognition particle (SRP), suppressing synthesis and secretion of immune effector proteins including interferons[4]. Due to its essential roles in replication and immune regulation, Nsp9 is considered a promising but still largely undrugged antiviral target for COVID-19 therapeutics[3][8].

Other names

Nsp9SARS-CoV-2 Nsp9Non-structural protein 9SARS-CoV-2 non-structural protein 9

Inhibition of RNA binding or dimerization may disrupt viral replication[3][4]. Targeting Nsp9 interactions with host proteins (e.g., NUP62) to impair viral evasion of immune response[5].